がん医療におけるゲノミクスの世界市場レポート 2025年

がん医療におけるゲノミクスの市場規模は今後数年で急成長が見込まれます。2029年にはCAGR16.8％で385億7,000万米ドルに成長します。予測期間の成長は、がん罹患率の増加、データ分析の進歩、新興国での市場拡大、ゲノムデータのプライバシーとセキュリティ、ヘルスケアインフラの改善などに起因すると考えられます。予測期間の主な動向には、技術の進歩、個別化医療、ゲノム配列決定のコスト削減、規制当局の支援とガイドライン、患者の意識と需要などがあります。

がん診断に対する需要の増加は、がん医療におけるゲノミクスの役割を後押しすると予測されます。がん診断には、病気の存在を確認するさまざまな検査や処置を通じて、腫瘍のタイプ、部位、範囲、病期を特定することが含まれます。がん医療におけるゲノミクスは、患者の遺伝子プロファイルを分析することで、適切な治療計画を立てる手助けをします。例えば、英国を拠点とするがん研究機関であるCancer Research UKの報告書（2024年7月）によると、英国における新規がん患者の年間平均数は、2023～2025年の約42万人から2038～2040年には約50万6,000人に増加すると予測されています。そのため、がん診断薬に対する需要の高まりが、がん医療市場におけるゲノミクスの進歩を促進すると予想されます。

がん医療におけるゲノミクス市場は、がんにおけるゲノミクス研究への資金提供や投資の増加によって成長を遂げています。がん医療におけるゲノミクス技術を推進する企業やイニシアチブには、多額の財源が向けられています。投資家は特に、包括的なゲノムプロファイリングとがん進行の非侵襲的モニタリングを提供する次世代シーケンシングプラットフォームからリキッドバイオプシーアッセイに至るまで、革新的技術の支援に関心を寄せています。特筆すべきは、ゲノム研究を促進するために英国政府が約1億7,500万ポンドという多額の投資を行ったことで、最先端のゲノムヘルスケアソリューションに対する資金援助が増加していることです。このような資金と投資の流入は、がん医療におけるゲノミクス市場の成長を促進する重要な要因です。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界のがん医療におけるゲノミクス市場のPESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界のがん医療におけるゲノミクス市場：成長率分析
• 世界のがん医療におけるゲノミクス市場の実績：規模と成長、2019～2024年
• 世界のがん医療におけるゲノミクス市場の予測：規模と成長、2024～2029年、2034年
• 世界のがん医療におけるゲノミクス総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のがん医療におけるゲノミクス市場：製品タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 機器
• 消耗品
• サービス
• 世界のがん医療におけるゲノミクス市場：技術別、実績と予測、2019～2024年、2024～2029年、2034年
• PCR（ポリメラーゼ連鎖反応）
• マイクロアレイ
• ゲノム配列解析
• その他
• 世界のがん医療におけるゲノミクス市場：用途別、実績と予測、2019～2024年、2024～2029年、2034年
• 診断
• 個別化医療
• 創薬と開発
• 研究
• 世界のがん医療におけるゲノミクス市場：エンドユーザー別、実績と予測、2019～2024年、2024～2029年、2034年
• 病院
• 政府機関
• 研究施設
• 世界のがん医療におけるゲノミクス市場：機器のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• シーケンサー
• PCR装置
• マイクロアレイ
• その他の診断機器
• 世界のがん医療におけるゲノミクス市場：消耗品のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 試薬とキット
• サンプル調製製品
• ヌクレオチド
• その他の消耗品
• 世界のがん医療におけるゲノミクス市場：サービスのサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• データ分析サービス
• バイオインフォマティクスサービス
• 遺伝子検査サービス
• その他のサポートサービス

第7章 地域別・国別分析

• 世界のがん医療におけるゲノミクス市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界のがん医療におけるゲノミクス市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• がん医療におけるゲノミクス市場：競合情勢
• がん医療におけるゲノミクス市場：企業プロファイル
  • Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • PerkinElmer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • QIAGEN N.V. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Bio-Rad Laboratories Inc.
• Danaher Corporation
• Pacific Biosciences of California Inc.
• Roche Holding AG
• Quest Diagnostics Incorporated
• DiaSorin S.p.A.
• BGI Group
• Myriad Genetics Inc.
• NeoGenomics Laboratories
• Foundation Medicine Inc.
• Intermountain Healthcare
• Laboratory Corporation of America Holdings
• Flatiron Health Inc.
• Personal Genome Diagnostics Inc.
• Natera Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• がん医療におけるゲノミクス市場2029年：新たな機会を提供する国
• がん医療におけるゲノミクス市場2029年：新たな機会を提供するセグメント
• がん医療におけるゲノミクス市場2029年：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Genomics in cancer care involves the comprehensive examination of all variations in DNA sequence and gene expression between tumor cells and healthy host cells. This approach aims to identify patients' genetic backgrounds for more effective cancer treatment. Genomics in cancer care is utilized to detect cancer-causing mutations, improve tumor-specific diagnostic techniques and treatment plans, facilitate precision medicine research and drug development, and enable the creation of targeted therapies to offer personalized treatment to patients with various types of cancers.

The main product types in genomics for cancer care include instruments, consumables, and services. Instruments are devices or equipment used for the detection of tumors in cancer genomics, providing accurate diagnostics. Various technologies, such as PCR, microarrays, genome sequencing, and others, are employed in these instruments. The applications of genomics in cancer care span diagnostics, personalized medicine, drug discovery and development, and research. These applications are utilized by hospitals, government institutes, and research facilities to enhance cancer diagnosis and treatment strategies.

The genomics in cancer care market research report is one of a series of new reports from The Business Research Company that provides genomics in cancer care market statistics, including genomics in cancer care industry global market size, regional shares, competitors with a genomics in cancer care market share, detailed genomics in cancer care market segments, market trends and opportunities, and any further data you may need to thrive in the genomics in cancer care industry. This genomics in cancer care market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The genomics in cancer care market size has grown rapidly in recent years. It will grow from $17.6 billion in 2024 to $20.73 billion in 2025 at a compound annual growth rate (CAGR) of 17.8%. The growth in the historic period can be attributed to early research and development, development of companion diagnostics, ethical and legal frameworks, data standardization and interpretation, initial market penetration.

The genomics in cancer care market size is expected to see rapid growth in the next few years. It will grow to $38.57 billion in 2029 at a compound annual growth rate (CAGR) of 16.8%. The growth in the forecast period can be attributed to increasing prevalence of cancer, advancements in data analytics, market expansion in emerging economies, genomic data privacy and security, improving healthcare infrastructure. Major trends in the forecast period include technological advancements, personalized medicine, reduced costs of genomic sequencing, regulatory support and guidelines, patient awareness and demand.

The increasing demand for cancer diagnostics is projected to boost the role of genomics in the cancer care market. Cancer diagnostics involves identifying the specific type, location, extent, and stage of tumors through various tests and procedures that confirm the presence of the disease. Genomics in cancer care aids in formulating appropriate treatment plans for patients by analyzing their genetic profiles. For instance, a report from Cancer Research UK, a UK-based cancer research organization, indicated in July 2024 that the average annual number of new cancer cases in the UK is anticipated to rise from approximately 420,000 cases between 2023 and 2025 to around 506,000 cases by 2038-2040. Therefore, the growing demand for cancer diagnostics is expected to drive the advancement of genomics in the cancer care market.

The genomics in cancer care market is experiencing growth, propelled by an increase in funding and investments for genomics research in cancer. Significant financial resources are being directed towards companies and initiatives advancing genomics technologies in cancer care. Investors are particularly interested in supporting innovative technologies, ranging from next-generation sequencing platforms to liquid biopsy assays, which provide comprehensive genomic profiling and non-invasive monitoring of cancer progression. Notably, the UK government's substantial investment of around £175 million to boost genomics research underscores the increasing financial support for cutting-edge genomic healthcare solutions. This influx of funding and investments is a key factor driving the growth of the genomics in cancer care market.

Leading companies in the genomics in cancer care market are prioritizing the introduction of robotic genomic testing facilities to improve the accuracy and efficiency of genetic testing, decrease turnaround times, and enhance patient outcomes through personalized treatment strategies tailored to individual genetic profiles. Robotic genomic testing facilities are advanced laboratory environments equipped with automated systems and robotic technologies designed to conduct various genomic analyses. For example, utilizing Automata's LINQ platform, the lab features six robotic arms that automate the preparation of samples from different biological materials, such as saliva, blood, bone marrow, and tissue biopsies. In September 2024, The Royal Marsden NHS Foundation Trust, a UK-based cancer hospital, launched a robotic genomic testing facility aimed at improving cancer diagnosis and treatment. This facility will double the genomic testing capacity of the Royal Marsden, enabling a higher volume of tests to be processed without sacrificing accuracy.

Major companies operating in the genomics in cancer care market are engaging in strategic partnerships to strengthen their positions. These partnerships involve structured affiliations between commercial enterprises, often established through business agreements or contracts. The collaboration between C2i Genomics and Karkinos Healthcare exemplifies this trend, where innovative cancer detection technology is brought together with the goal of driving research and development (R&D), establishing future pharma partnerships, and facilitating clinical use in India. Such strategic partnerships contribute to the expansion and global scalability of genomics in cancer care technologies, fostering growth and development in the market.

In December 2023, Pfizer Inc., a US-based company, completed the acquisition of Seagen Inc. for $43 billion. This acquisition is intended to enhance Pfizer's portfolio by integrating Seagen's expertise in delivering cancer care through innovative genomic approaches. Seagen Inc. specializes in providing cancer treatment using advanced genomic strategies.

Major companies operating in the genomics in cancer care market are Illumina Inc., Thermo Fisher Scientific Inc., Agilent Technologies Inc., PerkinElmer Inc., QIAGEN N.V., Bio-Rad Laboratories Inc., Danaher Corporation, Pacific Biosciences of California Inc., Roche Holding AG, Quest Diagnostics Incorporated, DiaSorin S.p.A., BGI Group, Myriad Genetics Inc., NeoGenomics Laboratories, Foundation Medicine Inc., Intermountain Healthcare, Laboratory Corporation of America Holdings, Flatiron Health Inc., Personal Genome Diagnostics Inc., Natera Inc., GRAIL Inc., Freenome Holdings Inc., Caris Life Sciences Inc., Tempus Labs Inc., OncoDNA S.A., Biocept Inc., GenomOncology Corp., OncoCyte Corporation, PathAI Inc., Enzyme Corporation, Karius Inc., N-of-One Inc., Oncora Medical Inc., Paradigm Diagnostics Inc., PierianDx Inc., Predicine Inc., Resolution Bioscience Inc., Strata Oncology Inc.

North America was the largest region in the genomics in cancer care market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genomics in cancer care market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the genomics in cancer care market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The genomics in the cancer care market consists of revenues earned by entities by providing sequencing to identify DNA and RNA alterations, and defining molecular subtypes. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Genomics In Cancer Care Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on genomics in cancer care market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for genomics in cancer care ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The genomics in cancer care market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product Type: Instruments; Consumables; Services
• 2) By Technology: PCR (Polymerase Chain Reaction); MicroArrays; Genome Sequencing; Other Technologies
• 3) By Application: Diagnostics; Personalized Medicine; Drug Discovery And Development; Research
• 4) By End-User: Hospitals; Government Institutes; Research Facilities
• Subsegments:
• 1) By Instruments: Sequencers; PCR Machines; Microarrays; Other Diagnostic Instruments
• 2) By Consumables: Reagents And Kits; Sample Preparation Products; Nucleotides; Other Consumables
• 3) By Services: Data Analysis Services; Bioinformatics Services; Genetic Testing Services; Other Support Services
• Companies Mentioned: Illumina Inc.; Thermo Fisher Scientific Inc.; Agilent Technologies Inc.; PerkinElmer Inc.; QIAGEN N.V.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Genomics In Cancer Care Market Characteristics

3. Genomics In Cancer Care Market Trends And Strategies

4. Genomics In Cancer Care Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Genomics In Cancer Care Growth Analysis And Strategic Analysis Framework

• 5.1. Global Genomics In Cancer Care PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Genomics In Cancer Care Market Growth Rate Analysis
• 5.4. Global Genomics In Cancer Care Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Genomics In Cancer Care Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Genomics In Cancer Care Total Addressable Market (TAM)

6. Genomics In Cancer Care Market Segmentation

• 6.1. Global Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Instruments
• Consumables
• Services
• 6.2. Global Genomics In Cancer Care Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• PCR (Polymerase Chain Reaction)
• MicroArrays
• Genome Sequencing
• Other Technologies
• 6.3. Global Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Diagnostics
• Personalized Medicine
• Drug Discovery And Development
• Research
• 6.4. Global Genomics In Cancer Care Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Government Institutes
• Research Facilities
• 6.5. Global Genomics In Cancer Care Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Sequencers
• PCR Machines
• Microarrays
• Other Diagnostic Instruments
• 6.6. Global Genomics In Cancer Care Market, Sub-Segmentation Of Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Reagents And Kits
• Sample Preparation Products
• Nucleotides
• Other Consumables
• 6.7. Global Genomics In Cancer Care Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Data Analysis Services
• Bioinformatics Services
• Genetic Testing Services
• Other Support Services

7. Genomics In Cancer Care Market Regional And Country Analysis

• 7.1. Global Genomics In Cancer Care Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Genomics In Cancer Care Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Genomics In Cancer Care Market

• 8.1. Asia-Pacific Genomics In Cancer Care Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Genomics In Cancer Care Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Genomics In Cancer Care Market

• 9.1. China Genomics In Cancer Care Market Overview
• 9.2. China Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Genomics In Cancer Care Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Genomics In Cancer Care Market

• 10.1. India Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Genomics In Cancer Care Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Genomics In Cancer Care Market

• 11.1. Japan Genomics In Cancer Care Market Overview
• 11.2. Japan Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Genomics In Cancer Care Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Genomics In Cancer Care Market

• 12.1. Australia Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Genomics In Cancer Care Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Genomics In Cancer Care Market

• 13.1. Indonesia Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Genomics In Cancer Care Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Genomics In Cancer Care Market

• 14.1. South Korea Genomics In Cancer Care Market Overview
• 14.2. South Korea Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Genomics In Cancer Care Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Genomics In Cancer Care Market

• 15.1. Western Europe Genomics In Cancer Care Market Overview
• 15.2. Western Europe Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Genomics In Cancer Care Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Genomics In Cancer Care Market

• 16.1. UK Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Genomics In Cancer Care Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Genomics In Cancer Care Market

• 17.1. Germany Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Genomics In Cancer Care Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Genomics In Cancer Care Market

• 18.1. France Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Genomics In Cancer Care Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Genomics In Cancer Care Market

• 19.1. Italy Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Genomics In Cancer Care Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Genomics In Cancer Care Market

• 20.1. Spain Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Genomics In Cancer Care Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Genomics In Cancer Care Market

• 21.1. Eastern Europe Genomics In Cancer Care Market Overview
• 21.2. Eastern Europe Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Genomics In Cancer Care Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Genomics In Cancer Care Market

• 22.1. Russia Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Genomics In Cancer Care Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Genomics In Cancer Care Market

• 23.1. North America Genomics In Cancer Care Market Overview
• 23.2. North America Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Genomics In Cancer Care Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Genomics In Cancer Care Market

• 24.1. USA Genomics In Cancer Care Market Overview
• 24.2. USA Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Genomics In Cancer Care Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Genomics In Cancer Care Market

• 25.1. Canada Genomics In Cancer Care Market Overview
• 25.2. Canada Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Genomics In Cancer Care Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Genomics In Cancer Care Market

• 26.1. South America Genomics In Cancer Care Market Overview
• 26.2. South America Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Genomics In Cancer Care Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Genomics In Cancer Care Market

• 27.1. Brazil Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Genomics In Cancer Care Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Genomics In Cancer Care Market

• 28.1. Middle East Genomics In Cancer Care Market Overview
• 28.2. Middle East Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Genomics In Cancer Care Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Genomics In Cancer Care Market

• 29.1. Africa Genomics In Cancer Care Market Overview
• 29.2. Africa Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Genomics In Cancer Care Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Genomics In Cancer Care Market Competitive Landscape And Company Profiles

• 30.1. Genomics In Cancer Care Market Competitive Landscape
• 30.2. Genomics In Cancer Care Market Company Profiles
  • 30.2.1. Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. PerkinElmer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. QIAGEN N.V. Overview, Products and Services, Strategy and Financial Analysis

31. Genomics In Cancer Care Market Other Major And Innovative Companies

• 31.1. Bio-Rad Laboratories Inc.
• 31.2. Danaher Corporation
• 31.3. Pacific Biosciences of California Inc.
• 31.4. Roche Holding AG
• 31.5. Quest Diagnostics Incorporated
• 31.6. DiaSorin S.p.A.
• 31.7. BGI Group
• 31.8. Myriad Genetics Inc.
• 31.9. NeoGenomics Laboratories
• 31.10. Foundation Medicine Inc.
• 31.11. Intermountain Healthcare
• 31.12. Laboratory Corporation of America Holdings
• 31.13. Flatiron Health Inc.
• 31.14. Personal Genome Diagnostics Inc.
• 31.15. Natera Inc.

32. Global Genomics In Cancer Care Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Genomics In Cancer Care Market

34. Recent Developments In The Genomics In Cancer Care Market

35. Genomics In Cancer Care Market High Potential Countries, Segments and Strategies

• 35.1 Genomics In Cancer Care Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Genomics In Cancer Care Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Genomics In Cancer Care Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer